Discounted Cash Flow (DCF) Analysis Levered

P3 Health Partners Inc. (PIII)

$4.69

+0.07 (+1.52%)
All numbers are in Millions, Currency in USD

Free Cash Flow

Year
A/P
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 145.89485.541,615.895,377.7317,897.1959,562.27198,224.56
Revenue (%)
Operating Cash Flow -28.29-24.60-197.57-657.53-2,188.28-7,282.66-24,236.85
Operating Cash Flow (%)
Capital Expenditure -1.45-2.93-12.91-42.97-142.99-475.87-1,583.71
Capital Expenditure (%)
Free Cash Flow -29.74-27.52-210.48-700.50-2,331.27-7,758.53-25,820.57

Weighted Average Cost Of Capital

Share price $ 4.69
Beta 0.000
Diluted Shares Outstanding 68.16
Cost of Debt
Tax Rate 9.49
After-tax Cost of Debt -%
Risk-Free Rate
Market Risk Premium
Cost of Equity 3.748
Total Debt 49.11
Total Equity 319.67
Total Capital 368.78
Debt Weighting 13.32
Equity Weighting 86.68
Wacc

Build Up Free Cash Flow

Year
A/P
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 145.89485.541,615.895,377.7317,897.1959,562.27198,224.56
Operating Cash Flow -28.29-24.60-197.57-657.53-2,188.28-7,282.66-24,236.85
Capital Expenditure -1.45-2.93-12.91-42.97-142.99-475.87-1,583.71
Free Cash Flow -29.74-27.52-210.48-700.50-2,331.27-7,758.53-25,820.57
WACC
PV LFCF ---2,331.27--
SUM PV LFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) -
Free cash flow (t + 1) -26,336.98
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt 12.85
Equity Value -
Shares Outstanding 68.16
Equity Value Per Share -